Skip to main content
. Author manuscript; available in PMC: 2014 Sep 4.
Published in final edited form as: Depress Anxiety. 2012 Dec 20;30(2):174–183. doi: 10.1002/da.22024

Table 1.

Characteristics of NESARC participants with anxiety symptoms at the wave 1 (baseline) interview with the subsequent occurrence and persistence of alcohol dependence at the time of the follow-up interview (wave 2).

Characteristics at baseline Alcohol dependence at follow-up Persistence of alcohol dependence

Absent Present Bivariate logistic regression analyses Absent Present Bivariate logistic regression analyses

N % N % OR (95% CI) p N % N % OR (95% CI) p


Alcohol self-medication of anxiety:
 Absent 1266 92.0 111 56.7 1.00 <0.001 253 84.0 68 48.2 1.00
 Present 113 8.0 77 43.3 9.96 (6.47-15.32) 53 16.0 68 51.8 6.45 (3.64-11.42) <0.001


Sex:
 Male 418 34.8 102 54.5 1.00 <0.001 139 51.7 79 58.3 1.00
 Female 961 65.2 86 45.5 0.40 (0.27-0.58) 167 48.3 57 41.7 0.69 (0.42-1.14) 0.144


Age (years):
 18-35 411 30.5 71 42.3 1.00 113 37.2 51 42.3 1.00
 36-49 463 34.0 78 41.6 0.83 (0.53-1.30) 0.412 110 35.0 58 44.1 0.99 (0.57-1.73) 0.984
 50+ 505 35.5 39 16.1 0.30 (0.19-0.49) <0.001 83 27.8 27 13.6 0.40 (0.22-0.72) 0.003


Race/ethnicity:
 White 1013 83.5 138 83.6 1.00 239 83.8 104 83.7 1.00
 Black 180 7.3 26 8.8 1.17 (0.67-2.03) 0.571 28 5.3 17 8.9 1.85 (0.81-4.24) 0.141
 Hispanic/Other 186 9.3 24 7.7 0.80 (0.431.49) 0.480 39 10.9 15 7.4 0.68 (0.26-1.79) 0.427


Education (years):
 <12 163 11.1 31 17.6 1.00 37 12.3 24 20.7 1.00
 ≥12 1216 88.9 157 82.4 0.59 (0.33-1.08) 0.085 269 87.7 112 79.3 0.54 (0.24-1.20) 0.128


Drinking patterna:
 <Daily 1244 90.0 126 66.5 1.00 260 84.7 86 65.1 1.00
 Daily/nearly daily 130 10.0 62 33.5 4.65 (3.09-6.97) <0.001 46 15.3 50 34.9 3.01 (1.69-5.36) <0.001


Drink levelb:
 <5 on drinking days 1263 90.8 120 64.5 1.00 252 82.3 74 56.1 1.00
 ≥5 on drinking days 113 9.2 66 35.5 7.19 (4.42-11.68) <0.001 54 17.7 60 43.9 4.45 (2.50-7.92) <0.001


Anxiety disorderc:
 GADd 430 31.1 73 37.7 1.34 (0.90-2.00) 0.139 110 34.5 57 39.7 1.21 (0.73-2.03) 0.448
 Panic disorder 102 7.2 25 13.6 1.94 (1.08-3.49) 0.028 31 9.6 22 14.9 1.57 (0.77-3.22) 0.209
 Social phobia 175 13.3 40 17.7 1.40 (0.87-2.26) 0.160 56 19.6 31 18.1 0.89 (0.46-1.73) 0.723
 Specific phobia 307 22.2 53 31.3 1.54 (1.02-2.33) 0.038 78 26.1 41 33.5 1.36 (0.77-2.42) 0.283
Anxiety symptoms without full criteria 708 50.9 79 39.1 0.61 (0.43-0.87) 0.007 132 42.6 51 35.2 0.75 (0.47-1.19) 0.221


Comorbidityc:
 Major depressive disorder 419 29.9 68 36.5 1.34 (0.87-2.09) 0.181 109 31.7 57 42.7 1.62 (0.95-2.75) 0.077
 Personality disorderse 593 43.8 118 64.3 2.32 (1.60-3.35) <0.001 174 57.4 89 66.3 1.38 (0.88-2.18) 0.158
 Non-alcohol drug use disorderf 28 2.3 26 15.7 7.70 (3.39-17.52) <0.001 17 6.0 25 20.7 3.69 (1.58-8.60) 0.003
 Nicotine dependence 430 31.6 118 66.0 4.32 (2.85-6.56) <0.001 159 51.8 94 70.2 2.03 (1.20-3.46) 0.010


Family history of alcoholism:
 Absent 733 54.0 67 31.6 1.00 124 42.2 47 29.6 1.00
 Present 646 46.0 121 68.4 2.70 (1.84-3.98) <0.001 182 57.8 89 70.4 1.87 (1.13-3.09) 0.016


Treatment of anxiety symptomsg:
 None 673 48.5 93 46.6 1.00 144 51.2 68 46.4 1.00
 Any 706 51.5 95 53.4 1.05 (0.71-1.54) 0.808 162 48.8 68 53.6 1.14 (0.67-1.95) 0.619
a

Indicates pattern of drinking in the past year. There is missing data for 5 participants for the sample to assess development of alcohol dependence.

b

Indicates the number of alcoholic drinks consumed on drinking days in the past year. There is missing data for 5 participants for the development sample, and missing data for 2 participants in the persistence sample.

c

Diagnostic categories are not mutually exclusive.

d

GAD, generalized anxiety disorder.

e

Includes antisocial, narcissistic, histrionic, borderline, schizoid, schizotypal, paranoid, obsessive-compulsive, dependent and avoidant personality disorders.

f

Includes lifetime history of abuse and/or dependence on non-alcohol substances: heroin, other opioids, cocaine, cannabis, stimulants, and/or hallucinogens.

g

Indicates any lifetime treatment history of anxiety symptoms including outpatient therapy, medication treatment and/or inpatient hospitalization.